Trace Biosciences Announces FDA IND Clearance for First Nerve-Specific Imaging Agent
PR Newswire —
PORTLAND, Ore., Jan. 31, 2026 /PRNewswire/ -- Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-targeted imaging agents, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for...